Live feed
Filing
SC 13G/A
SC 13G/A0000902664-18-003676·Adaptimmune Therapeutics PLC
Schedule 13G ownership disclosure
ADAPTIMMUNE THERAPEUTICS PLC
Security class unavailable · CUSIP: 00653A107
Event date: 2018-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 122,172,066
- Percent of class
- 19.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-18-003676
- Form type
- SC 13G/A
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- Oct 10, 2018
- Reporting period
- Sep 30, 2018
- Description
- Schedule 13G beneficial ownership